BIOMAT Database Logo BIOMAT Database Logo

Frequency of protease and reverse transcriptase drug resistance mutations in naïve HIV-infected patients. 2006

Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca, México.

BACKGROUND Infections with drug-resistant HIV viruses in naïve subjects may cause antiretroviral (ARV) treatment failure. The prevalence of ARV resistance mutations in HIV-1 transcripts of infected naïve patients from northeast Mexico was determined in this study. METHODS RNA was extracted from plasma samples of 42 naïve individuals who were diagnosed between February 2001 and September 2003 as HIV-1 infected. Both protease (Pr) and reverse transcriptase (RT) were sequenced in 30 patients. In six samples only the RT segment was sequenced and in three samples only the protease segment was analyzed. RESULTS One of 36 isolates (2.8%) had the M184V resistance mutation to nucleoside retrotranscriptase inhibitors. In the Pr segment, only minor mutations were detected in 27/33 isolates (81.8%). CONCLUSIONS In this first study, prevalence of major mutations associated with ARV resistance in naïve patients in northeast Mexico is low compared to other countries, perhaps due to a low level of exposure of this population to ARV drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III

Related Publications

Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
January 2020, PloS one,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
January 2007, AIDS (London, England),
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon.
February 2010, Journal of medical virology,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania.
June 2008, AIDS research and therapy,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.
January 2002, HIV clinical trials,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
March 2007, Journal of medical virology,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.
January 2005, Antiviral therapy,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Baseline E138 reverse transcriptase resistance-associated mutations in antiretroviral-naive HIV-infected patients.
June 2012, AIDS (London, England),
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
April 2006, The new microbiologica,
Olivia M Valle-Bahena, and Javier Ramos-Jiménez, and Rocío Ortiz-López, and Agnès Revol, and Angel Lugo-Trampe, and Hugo A Barrera-Saldaña, and Augusto Rojas-Martínez
Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
March 2010, The Southeast Asian journal of tropical medicine and public health,
Copied contents to your clipboard!